Case Studies Pioneering precision medicine to diagnose, treat, and prevent neurodegeneration

Edit This Case Study Record

	Pioneering precision medicine to diagnose, treat, and prevent neurodegeneration

Pioneering precision medicine to diagnose, treat, and prevent neurodegeneration

Technology Category	Application Infrastructure & Middleware - Data Exchange & Integration Application Infrastructure & Middleware - Data Visualization Platform as a Service (PaaS) - Data Management Platforms
Applicable Industries	Healthcare & Hospitals Life Sciences
Applicable Functions	Product Research & Development Quality Assurance
Use Cases	Machine Condition Monitoring Predictive Maintenance
Services	Cloud Planning, Design & Implementation Services Data Science Services
Challenge	AC Immune, a clinical-stage biopharmaceutical company, was facing challenges in harmonizing data quality and standardization across the company. The R&D teams were using lab notebooks and spreadsheet-based software for data storage, analysis, and sharing, which was time-consuming. The company wanted to speed up crucial handoffs by offering the ability to easily search and interact with data across teams, experiments, and sites. Furthermore, AC Immune was looking for a systematized approach for capturing, sharing, and referencing data to boost data-driven decision-making for cross-functional projects. Read More
About Customer	AC Immune is a clinical-stage biopharmaceutical company that is leading in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications. The company has two clinically validated technology platforms that fuel its pipeline targeting disease-driving misfolded proteins. The SupraAntigen® platform generates therapeutic vaccines and antibodies with high target specificity, while the Morphomer® platform generates small molecule ligands as therapeutic drugs or brain imaging diagnostic agents. The company aims to shift the treatment paradigm of neurodegenerative disease towards earlier diagnosis and disease prevention. AC Immune is headquartered in Lausanne, Switzerland and has around 150 employees. Read More
Solution	AC Immune implemented Benchling, a cloud-based data management platform, to improve data capture and quality. The research teams now leverage standardized protocols, workflows, and schemas on Benchling, which strengthens consistency across the organization, leading to better data standardization and searchability. Benchling enables real-time interactions across the company. Since the platform is built for life science research, it boosts collaboration while promoting strong usability and adoption. The platform also provides automated data visualization and reporting features, improving scientific and operational insights while maintaining FAIR (Findable, Accessible, Interoperable and Reusable) data compliance. Read More Log in to view content
Contents

Technology Category

Application Infrastructure & Middleware - Data Exchange & Integration

Application Infrastructure & Middleware - Data Visualization

Platform as a Service (PaaS) - Data Management Platforms

Applicable Industries

Healthcare & Hospitals

Life Sciences

Applicable Functions

Product Research & Development

Quality Assurance

Use Cases

Machine Condition Monitoring

Predictive Maintenance

Services

Cloud Planning, Design & Implementation Services

Data Science Services

Challenge

AC Immune, a clinical-stage biopharmaceutical company, was facing challenges in harmonizing data quality and standardization across the company. The R&D teams were using lab notebooks and spreadsheet-based software for data storage, analysis, and sharing, which was time-consuming. The company wanted to speed up crucial handoffs by offering the ability to easily search and interact with data across teams, experiments, and sites. Furthermore, AC Immune was looking for a systematized approach for capturing, sharing, and referencing data to boost data-driven decision-making for cross-functional projects.

About Customer

AC Immune is a clinical-stage biopharmaceutical company that is leading in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications. The company has two clinically validated technology platforms that fuel its pipeline targeting disease-driving misfolded proteins. The SupraAntigen® platform generates therapeutic vaccines and antibodies with high target specificity, while the Morphomer® platform generates small molecule ligands as therapeutic drugs or brain imaging diagnostic agents. The company aims to shift the treatment paradigm of neurodegenerative disease towards earlier diagnosis and disease prevention. AC Immune is headquartered in Lausanne, Switzerland and has around 150 employees.

Solution

AC Immune implemented Benchling, a cloud-based data management platform, to improve data capture and quality. The research teams now leverage standardized protocols, workflows, and schemas on Benchling, which strengthens consistency across the organization, leading to better data standardization and searchability. Benchling enables real-time interactions across the company. Since the platform is built for life science research, it boosts collaboration while promoting strong usability and adoption. The platform also provides automated data visualization and reporting features, improving scientific and operational insights while maintaining FAIR (Findable, Accessible, Interoperable and Reusable) data compliance.

Impact #1	Improved traceability with 93% of users accrediting AC Immune and Benchling collaboration for improving storage, retrieval, and management of historical data and protocols across teams.
Impact #2	Saved 4 hours per week per scientist, increasing efficiency of data-sharing with colleagues and reducing time spent on logistical tasks, search, and data compilation.
Impact #3	After 6 months, 75% of users said having a unified system enhances their ability to make machine learning models to guide scientific decisions.

Impact #1

Improved traceability with 93% of users accrediting AC Immune and Benchling collaboration for improving storage, retrieval, and management of historical data and protocols across teams.

Impact #2

Saved 4 hours per week per scientist, increasing efficiency of data-sharing with colleagues and reducing time spent on logistical tasks, search, and data compilation.

Impact #3

After 6 months, 75% of users said having a unified system enhances their ability to make machine learning models to guide scientific decisions.

Benefit #1	93% improvement in data traceability.
Benefit #2	4 hours saved per week per scientist.
Benefit #3	75% of users reported enhanced ability to make machine learning models.

Benefit #1

93% improvement in data traceability.

Benefit #2

4 hours saved per week per scientist.

Benefit #3

75% of users reported enhanced ability to make machine learning models.

Download PDF Version

Overview

Pioneering precision medicine to diagnose, treat, and prevent neurodegeneration

Operational Impact

Quantitative Benefit